News
TSO3 Awarded Low Temperature Sterilization Contract Pursuant to a Quebec Tender
Tuesday, October 30, 2018
News
TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018
Thursday, October 25, 2018
TSO3 Inc. (TSX: TOS), (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 7, 2018 to discuss its financial results for the third quarter ended September 30, 2018.
TSO3’s President and CEO R.M. (Ric) Rumble and CFO Glen Kayll, will host the conference.
News
TSO3 Provides a Commercialization Update
Thursday, October 4, 2018
Myrtle Beach, S.C. and Quebec City, Canada – October 4, 2018 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, provided an update regarding the Company’s commercialization of the Company’s STERIZONE® VP4 Sterilizer. Readers are encouraged to visit the TSO3 website, www.tso3.com, to read the letter to shareholders posted on October 4, 2018, which outlines the Company’s progress to date and provides additional supporting information.